Dolby Laboratories (NYSE:DLB) SVP Shriram Revankar Sells 3,000 Shares of Stock

Dolby Laboratories (NYSE:DLB) SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $54.90, for a total transaction of $164,700.00. Following the completion of the transaction, the senior vice president owned 80,603 shares in the company, valued at $4,425,104.70. This represents a 3.59% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Dolby Laboratories Stock Down 1.9%

Shares of DLB stock opened at $53.32 on Wednesday. The stock has a fifty day moving average of $60.64 and a 200 day moving average of $63.59. Dolby Laboratories has a 52 week low of $53.20 and a 52 week high of $77.14. The firm has a market capitalization of $5.04 billion, a price-to-earnings ratio of 21.08 and a beta of 0.86.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, topping analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The company had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. During the same quarter last year, the firm posted $1.34 earnings per share. The firm’s revenue was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Equities research analysts anticipate that Dolby Laboratories will post 3.22 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be paid a $0.36 dividend. The ex-dividend date of this dividend is Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a yield of 2.7%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 56.92%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on DLB shares. Rosenblatt Securities reaffirmed a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, January 30th. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 price target on shares of Dolby Laboratories in a research note on Monday, April 27th. Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Dolby Laboratories currently has an average rating of “Moderate Buy” and an average price target of $90.75.

Hedge Funds Weigh In On Dolby Laboratories

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Boothbay Fund Management LLC lifted its position in Dolby Laboratories by 4.1% during the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock valued at $299,000 after buying an additional 157 shares during the period. Covestor Ltd lifted its position in Dolby Laboratories by 6.0% during the fourth quarter. Covestor Ltd now owns 3,088 shares of the electronics maker’s stock valued at $198,000 after buying an additional 175 shares during the period. Fifth Third Bancorp lifted its position in Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after buying an additional 192 shares during the period. State of Michigan Retirement System raised its position in shares of Dolby Laboratories by 1.4% in the 1st quarter. State of Michigan Retirement System now owns 14,700 shares of the electronics maker’s stock worth $883,000 after purchasing an additional 200 shares during the last quarter. Finally, Gabelli Funds LLC raised its position in shares of Dolby Laboratories by 0.4% in the 3rd quarter. Gabelli Funds LLC now owns 49,143 shares of the electronics maker’s stock worth $3,556,000 after purchasing an additional 202 shares during the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.